Gohealth (GOCO) Stock Price

Gohealth Price

NASDAQ·CLOSED
0.34
​
Market closed

Revenue has compounded at 6.9% per year over the past 7 years to 361.85 M USD. Gohealth's net margin stands at -71.1%, down from -17.8% several years earlier. Analysts set a median price target of 0.92 USD, implying 172.4% above the current price. Of 11 analysts, 1 rate the stock a buy — an overall Sell consensus.

Gohealth stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gohealth business model & stock analysis

Gohealth, Inc. engages in the provision of insurance services and will operates as a holding company. The company is headquartered in Chicago, Illinois and currently employs 1,857 full-time employees. The company went IPO on 2020-07-15. Its technology platform leverages modern machine-learning algorithms powered by insurance behavioral data to reimagine the optimal process for helping individuals find the health insurance plan for their specific needs. The firm operates its business in four segments: Medicare-Internal; Medicare-External; Individual and Family Plans (IFP) and Other-Internal, and IFP and Other-External. The Medicare segments focus on sales of Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans (SNPs) for multiple carriers. The Medicare Internal segments primarily consist of sales of products and plans offering qualified prospects plans from multiple carriers. The Company’s employed agents offering qualified prospects plans on a carrier-specific basis, or sales of products and plans through its online platform without the assistance of its agents, which is referred as do it yourself (DIY).

Frequently asked questions about Gohealth

Analysts currently set an average price target of 0.97 USD for the Gohealth stock (median: 0.92 USD), implying +187.5 % versus the latest price. The consensus is based on 11 analyst ratings.

8 analysts currently rate the Gohealth stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Gohealth to generate revenue of 256.47 M USD and earnings per share of -11.84 USD.

Converted at the current exchange rate, the Gohealth share trades at 0.30 EUR (0.34 USD).

The Gohealth share (GOCO) is listed on 1 stock exchanges, including: NASDAQ (GOCO).

The expected revenue of Gohealth is 256.47 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Gohealth is -153.17 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Gohealth is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Gohealth stock.

The price-to-sales ratio (P/S) of Gohealth is currently 0.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Gohealth stock.

The Eulerpool Quality Score for Gohealth is 2/10.

The ISIN of Gohealth is US38046W2044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Gohealth is A2P7L1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Gohealth is GOCO. The ticker symbol is used to trade Gohealth shares on the stock exchange.

Fair ValueTerminal
0.28 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Insurance
Number of shares
Employees
Revenue per Employee
425,700.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website gohealth.com
Currency
USD
Initial public offering
Jul 15, 2020
ISIN
US38046W2044
Cusip
38046W105
Sedol
BK80YC1
Market capitalization
9.68 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.03
P/Ee 2027
-0.04
P/Ee 2028
-0.28
P/Ee 2029
0.04
P/S
P/Se
0.02
EV/EBIT
—
P/B Ratio
0.10
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-33.51 %
Last updated Oct 31, 2026, 7:26 PM

All fundamentals and in-depth analysis of Gohealth

Our stock analysis for Gohealth stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gohealth. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.